Both in R&D — Physical & Biological Sciences
IB Acquisition vs iSpecimen
Over the past year IBAC returned +3.7% and ISPC returned −96.7%; their daily moves had a correlation of -0.05.
IBAC +3.7% ISPC −96.7%Growth of $1, one year, split-adjusted
| Metric | IBAC | ISPC |
|---|---|---|
| Price | $10.81 | $0.7969 |
| Market cap | $54.1M | $2.0M |
| Today | −0.46% | −5.47% |
| 1 month | −0.6% | −27.6% |
| 6 months | −0.2% | −84.9% |
| Year to date | +3.0% | −92.3% |
| 1 year | — | −96.9% |
| Revenue growth (YoY) | — | −78.7% |
| Gross margin | — | 45.2% |
| Net margin | — | −896.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.3× |
| Net cash | — | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 20.1% | 86.5% |
| Short % of float | 0.3% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).